An Emerging Trend of Methamphetamine Injection in Iran: A Critical Target for Research on Blood-Borne Infection Diseases

authors:

avatar Zahra Alam Mehrjerdi 1 , * , avatar Alireza Noroozi 2

Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, IR Iran
Iranian National Center for Addiction Studies (INCAS), School of Advanced Medical Technologies (SAMT), Tehran University of Medical Sciences, Tehran, IR Iran
Hepatitis Monthly: Vol.13, issue 2; e8154
published online: February 28, 2013
article type: Editorial
received: September 12, 2012
revised: October 1, 2012
accepted: October 16, 2012
DOI: https://doi.org/10.5812/hepatmon.8154

how to cite: Alam Mehrjerdi Z, Noroozi A. An Emerging Trend of Methamphetamine Injection in Iran: A Critical Target for Research on Blood-Borne Infection Diseases. Hepat Mon. 2013;13(2):e8154. https://doi.org/10.5812/hepatmon.8154.

References

  • 1.

    Mirahmadizadeh AR, Majdzadeh R, Mohammad K, Forouzanfar MH. Prevalence of HIV and hepatitis C virus infections and related behavioral determinants among injecting drug users of drop-in centers in Iran. Iran Red Crescent Med J. 2009;11(3):325-9.

  • 2.

    Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis. 2010;14(1):e28-33. [PubMed ID: 19464218]. https://doi.org/10.1016/j.ijid.2009.03.002.

  • 3.

    Nokhodian Z, Meshkati M, Adibi P, Ataei B, Kassaian N, Yaran M, et al. Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors. Int J Prev Med. 2012;3(Suppl 1):S131-8. [PubMed ID: 22826755].

  • 4.

    Halkitis PN, Parsons JT, Stirratt MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex. 2001;41(2):17-35. [PubMed ID: 11482426]. https://doi.org/10.1300/J082v41n02_02.

  • 5.

    Molitor F, Ruiz JD, Flynn N, Mikanda JN, Sun RK, Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse. 1999;25(3):475-93. [PubMed ID: 10473010].

  • 6.

    Shoptaw S, Reback CJ. Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction. 2007;102 Suppl 1:130-5. [PubMed ID: 17493062]. https://doi.org/10.1111/j.1360-0443.2006.01775.x.

  • 7.

    Brewer DD, Golden MR, Handsfield HH. Unsafe sexual behavior and correlates of risk in a probability sample of men who have sex with men in the era of highly active antiretroviral therapy. Sex Transm Dis. 2006;33(4):250-5. [PubMed ID: 16505748]. https://doi.org/10.1097/01.olq.0000194595.90487.ed.

  • 8.

    Semple SJ, Grant I, Patterson TL. Female methamphetamine users: social characteristics and sexual risk behavior. Women Health. 2004;40(3):35-50. [PubMed ID: 15829444].

  • 9.

    Carey JW, Mejia R, Bingham T, Ciesielski C, Gelaude D, Herbst JH, et al. Drug use, high-risk sex behaviors, and increased risk for recent HIV infection among men who have sex with men in Chicago and Los Angeles. AIDS Behav. 2009;13(6):1084-96. [PubMed ID: 18498049]. https://doi.org/10.1007/s10461-008-9403-3.

  • 10.

    Schwarcz S, Scheer S, McFarland W, Katz M, Valleroy L, Chen S, et al. Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men. Am J Public Health. 2007;97(6):1067-75. [PubMed ID: 17463384]. https://doi.org/10.2105/AJPH.2005.072249.

  • 11.

    Lorvick J, Martinez A, Gee L, Kral AH. Sexual and injection risk among women who inject methamphetamine in San Francisco. J Urban Health. 2006;83(3):497-505. [PubMed ID: 16739050]. https://doi.org/10.1007/s11524-006-9039-4.

  • 12.

    Semple SJ, Patterson TL, Grant I. The context of sexual risk behavior among heterosexual methamphetamine users. Addict Behav. 2004;29(4):807-10. [PubMed ID: 15135564]. https://doi.org/10.1016/j.addbeh.2004.02.013.

  • 13.

    Greenwell L, Brecht ML. Self-reported health status among treated methamphetamine users. Am J Drug Alcohol Abuse. 2003;29(1):75-104. [PubMed ID: 12731682].

  • 14.

    Vogt TM, Perz JF, Van Houten CK, Jr, Harrington R, Hansuld T, Bialek SR, et al. An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment. Addiction. 2006;101(5):726-30. [PubMed ID: 16669906]. https://doi.org/10.1111/j.1360-0443.2006.01407.x.

  • 15.

    Boddiger D. Metamphetamine use linked to rising HIV transmission. Lancet. 2005;365(9466):1217-8. [PubMed ID: 15816071]. https://doi.org/10.1016/S0140-6736(05)74794-2.

  • 16.

    ed. Vienna, Austria; 2012. World drug report. Available from: http://www.unodc.org/documents/data-and-analysis/WDR2012/WDR_2012_web_small.pdf.

  • 17.

    Zarghami M. Methamphetamine has changed the profile of patients utilizing psychiatric emergency services in Iran. Iran J Psychiatr Behav Sci. 2011;5(1):1-5.

  • 18.

    Momtazi S, Rawson R. Substance abuse among Iranian high school students. Curr Opin Psychiatry. 2010;23(3):221-6. [PubMed ID: 20308905]. https://doi.org/10.1097/YCO.0b013e328338630d.

  • 19.

    Mokhber N, Afshari R, Farhoodi F. Evaluation of the suicide risk factors among methadone maintenance treatment of opiate dependent individuals: A six month assessment. Open J Psychiatry. 2012;2(2):91-5.

  • 20.

    Rafiey H, Narenjiha H, Shirinbayan P, Noori R, Javadipour M, Roshanpajouh M, et al. Needle and syringe sharing among Iranian drug injectors. Harm Reduct J. 2009;6:21. [PubMed ID: 19643014]. https://doi.org/10.1186/1477-7517-6-21.

  • 21.

    Razzaghi E, Nassirimanesh B, Afshar P, Ohiri K, Claeson M, Power R. HIV/AIDS harm reduction in Iran. Lancet. 2006;368(9534):434-5. [PubMed ID: 16890814]. https://doi.org/10.1016/S0140-6736(06)69132-0.

  • 22.

    Vazirian M, Nassirimanesh B, Zamani S, Ono-Kihara M, Kihara M, Ravari SM, et al. Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study. Harm Reduct J. 2005;2:19. [PubMed ID: 16212655]. https://doi.org/10.1186/1477-7517-2-19.

  • 23.

    Rose VJ, Raymond HF, Kellogg TA, McFarland W. Assessing the feasibility of harm reduction services for MSM: the late night breakfast buffet study. Harm Reduct J. 2006;3:29. [PubMed ID: 17018154]. https://doi.org/10.1186/1477-7517-3-29.

  • 24.

    Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14-9. [PubMed ID: 15047779]. https://doi.org/10.1093/jurban/jth083.